Theratechnologies Inc. (THTX) Tops Q3 EPS by 4c

Theratechnologies Inc. (NASDAQ: THTX) reported Q3 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $20.67 million.

GUIDANCE:

Theratechnologies Inc. sees FY2022 revenue of $79-82 million.

For earnings history and earnings-related data on Theratechnologies Inc. (THTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c